Dr Kaeleigh Nicole Bochat, OD is a
Optometrist based in Bulverde, Texas. Dr Kaeleigh Nicole Bochat is licensed to practice in Texas (license number 10319T) and her current practice location is
121 Bulverde Crossing Rd Ste 124, Bulverde, Texas. She can be reached at her office (for appointments etc.) via phone at
(830) 980-2020.
NPI number for Dr Kaeleigh Nicole Bochat is 1235708090 and her current mailing address is 121 Bulverde Crossing Rd Ste 124, Bulverde, Texas. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1235708090.
Healthcare Provider's Profile
Full Name | Dr Kaeleigh Nicole Bochat |
---|
Gender | Female |
---|
Speciality | Optometrist |
---|
Location | 121 Bulverde Crossing Rd Ste 124, Bulverde, Texas |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1235708090
- Provider Enumeration Date: 06/24/2021
- Last Update Date: 06/24/2021
Medical Identifiers
Medical identifiers for Dr Kaeleigh Nicole Bochat such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1235708090 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
152W00000X | Optometrist | 10319T (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Kaeleigh Nicole Bochat is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Dr Kaeleigh Nicole Bochat, OD 121 Bulverde Crossing Rd Ste 124, Bulverde, TX 78163-6201 Ph: (830) 980-2020 | Dr Kaeleigh Nicole Bochat, OD 121 Bulverde Crossing Rd Ste 124, Bulverde, TX 78163-6201 Ph: (830) 980-2020 |
Reviews and Comments